NFKBIZ

protein-coding

NFKB inhibitor zeta, the group of Ankyrin repeat domain containing

Gene summary

This gene is a member of the ankyrin-repeat family and is induced by lipopolysaccharide (LPS). The C-terminal portion of the encoded product which contains the ankyrin repeats, shares high sequence similarity with the I kappa B family of proteins. The latter are known to play a role in inflammatory responses to LPS by their interaction with NF-B proteins through ankyrin-repeat domains. Studies in mouse indicate that this gene product is one of the nuclear I kappa B proteins and an activator of IL-6 production. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

MANE transcript

NM_031419.4

Inheritance

—

ClinVar variants

U:95B:9

Top phenotype

NFKBIZ-related disorder

gnomAD constraint

pLI —, LoF o/e 0.06

Max pathogenic AF

—

Genomic locus

chr3:101,827,991-101,861,022

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~33.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

hereditary nonpolyposis colon cancerLIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0018630

Submitter: ClinGen

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to NFKBIZ variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 86
not providedTotal: 3
NFKBIZ-related disorderTotal: 2
EBV-positive nodal T- and NK-cell lymphomaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_031419.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
clinvar
2
missense
84
clinvar
8
clinvar
92
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
10
clinvar
10
Total009590104
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 12 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_031419.4RefSeqNP_113607.112MANE Select
ENST00000326172.9EnsemblENSP00000325663.512MANE Select
NM_001005474.3RefSeqNP_001005474.111Standard
ENST00000326151.10EnsemblENSP00000325593.513Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Transcriptional misregulation in cancer - Homo sapiens (human)
  • TNFalpha

Biological Process

  • inflammatory response
  • positive regulation of inflammatory response
  • T cell receptor signaling pathway
  • positive regulation of T-helper 17 cell differentiation

Molecular Function

  • protein binding

Cellular Component

  • nucleus
  • nuclear speck
  • cytoplasmic ribonucleoprotein granule

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000326172
Coding exons
12
Length
33032
Individuals with no LoFs
125746
Homozygous LoFs
0
Heterozygous LoFs
2
Defined
125748
p
0.00000795
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.182993620.8250.00001884695
Missense (PolyPhen)60105.50.568721355
Synonymous-1.231561381.130.000007491405
Loss of Function5.02233.20.06020.00000169372

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.00000880.0000088rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in regulation of NF-kappa-B transcription factor complexes. Inhibits NF-kappa-B activity without affecting its nuclear translocation upon stimulation. Inhibits DNA-binding of RELA and NFKB1/p50, and of the NF-kappa-B p65-p50 heterodimer and the NF-kappa-B p50-p50 homodimer. Seems also to activate NF- kappa-B-mediated transcription. In vitro, upon association with NFKB1/p50 has transcriptional activation activity and, together with NFKB1/p50 and RELA, is recruited to LCN2 promoters. Promotes transcription of LCN2 and DEFB4. Is recruited to IL-6 promoters and activates IL-6 but decreases TNF-alpha production in response to LPS. Seems to be involved in the induction of inflammatory genes activated through TLR/IL-1 receptor signaling. May promote apoptosis (By similarity). Involved in the induction of T helper 17 cells (Th17) differentiation upon recognition of antigen by T cell antigen receptor (TCR) (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q9EST8, ECO:0000269|PubMed:16513645, ECO:0000269|PubMed:16622025}.;

Recessive Scores

pRec
0.0971

Intolerance Scores

RVIS EVS
-0.62
RVIS percentile EVS
17.31

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.373

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.